Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vivani Medical, Inc. - Common Stock
(NQ:
VANI
)
1.670
+0.040 (+2.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Vivani Medical, Inc. - Common Stock
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
May 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at TIDES Conference 2024
May 09, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
March 06, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher
Via
MarketBeat
Exposures
Product Safety
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
March 01, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
February 28, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
November 14, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at BIO Investor Forum
October 16, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at the Boulder Peptide Symposium
September 07, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10
September 05, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Reports Second Quarter Financial Results and Provides Business Update
August 14, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System
July 11, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
June 14, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Reports First Quarter Financial Results and Provides Business Update
May 15, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
April 04, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 31, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division
March 21, 2023
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates
November 14, 2022
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at the ThinkEquity Investor Conference
October 17, 2022
From
Vivani Medical, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.